ArticleCureus2025
Restoring the Flow: Observational Outcomes of Endoscopic Endonasal Dacryocystorhinostomy in a Tertiary Care Institution.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionNasolacrimal duct obstruction is a clinical condition characterized by epiphora and both acute and chronic dacryocystitis. Endoscopic endonasal dacryocystorhinostomy (EE DCR) is the treatment of choice for chronic dacryocystitis. This study aimed to evaluate the anatomical and functional success, safety profile, and patient-reported outcomes of EE DCR in chronic dacryocystitis in a tertiary care center.
methodA retrospective review of 50 patients who underwent EE DCR between January 2020 and January 2025 was conducted. Data on demographics, clinical presentation, surgical technique, postoperative outcomes, and complications were gathered. Symptomatic improvement was measured using the Nasolacrimal Duct Obstruction Symptom Score (NLDO-SS), and quality of life was assessed using a validated questionnaire both preoperatively and postoperatively at six months. Statistical analysis was performed using IBM SPSS Statistics for Windows, Version 26 (Released 2019; IBM Corp., Armonk, New York).
resultsThe mean age was 35.2 ± 13.3 years with a female predominance of 31 (62%). Epiphora was the chief complaint in 42 (84%) of cases. At six months, anatomical patency was achieved in 48 (96%), and subjective symptom resolution occurred in 49 (98%). Mean NLDO-SS and quality of life scores improved significantly (P < 0.001). Complications were reported in 6 patients (12%), including intraoperative hemorrhage in 2 (4%), postoperative adhesions in 2 (4%), and granulation tissue formation in 2 (4%). No vision-threatening events were recorded.
conclusionEE DCR demonstrates high anatomical and functional success with low complication rates, offering a minimally invasive and effective alternative to external DCR. The procedure yields substantial improvements in patient symptoms and quality of life. Further prospective studies with larger cohorts and longer follow-up periods are warranted to validate these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.